NCT02204930View on ClinicalTrials.gov

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Hemorrhage
Interventions
DRUG

PeproStat

A solution of PeproStat containing up to 9.25mg protein soaked immediately prior to use onto a Gelita-Spon® gelatin sponge.

Trial Locations (4)

B15 2TH

Queen Elizabeth Hospital, Birmingham

CB2 0QQ

Addenbrooke's University Hospital, Cambridge

SE5 9RS

Kings University Hospital, London

PL6 8DH

Derriford Hospital, Plymouth

Sponsors

Lead Sponsor

Haemostatix Ltd
All Listed Sponsors
lead

Haemostatix Ltd

INDUSTRY